Literature DB >> 26856913

Limited Degradation of the Plasmodium falciparum Gametocyte Marker pfs25 mRNA Exposed to Tropical Temperatures: Considerations for Malaria Transmission Field Studies.

Andreea Waltmann1, Stephan Karl2, Chris Chiu2, Ivo Mueller2.   

Abstract

An important aspect of many malaria molecular epidemiology and transmission studies is RNA-based detection of gametocytes. Ensuring RNA stability represents a challenge in tropical, resource-limited environments, as RNA may quickly degrade when samples are not preserved under adequate conditions. This study investigated the degradation of pfs25 messenger RNA (mRNA), the most widely used Plasmodium falciparum gametocyte marker, in whole blood spiked with cultured P. falciparum gametocytes, exposed to different temperatures for up to 48 hours, and collected with different anticoagulants. The levels of pfs25 mRNA were similar between samples stored at 4°C and 30°C for up to 48 hours before stabilization with RNAprotect (Qiagen, Hilden, Germany). We observed that pfs25 mRNA in heparin-collected blood degraded less than that in ethylenediaminetetraacetic acid (EDTA)-collected blood over the 48-hour period. For field studies aiming for P. falciparum gametocyte detection, immediate stabilization of blood samples is not necessary, as the pfs25 transcript is relatively stable, more so in heparin than EDTA collection tubes. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26856913      PMCID: PMC4824233          DOI: 10.4269/ajtmh.15-0531

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  14 in total

1.  Purification and characterization of PCR-inhibitory components in blood cells.

Authors:  W A Al-Soud; P Rådström
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

2.  Stabilization of mRNA expression in whole blood samples.

Authors:  Lynne Rainen; Uwe Oelmueller; Stewart Jurgensen; Ralf Wyrich; Cynthia Ballas; Jim Schram; Chris Herdman; Danute Bankaitis-Davis; Nancy Nicholls; David Trollinger; Victor Tryon
Journal:  Clin Chem       Date:  2002-11       Impact factor: 8.327

3.  Interactions with heparin-like molecules during erythrocyte invasion by Plasmodium falciparum merozoites.

Authors:  Michelle J Boyle; Jack S Richards; Paul R Gilson; Wengang Chai; James G Beeson
Journal:  Blood       Date:  2010-03-10       Impact factor: 22.113

Review 4.  Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination.

Authors:  Teun Bousema; Chris Drakeley
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

5.  Filter paper collection of Plasmodium falciparum mRNA for detecting low-density gametocytes.

Authors:  Sophie Jones; Colin J Sutherland; Cornelus Hermsen; Theo Arens; Karina Teelen; Rachel Hallett; Patrick Corran; Marga van der Vegte-Bolmer; Robert Sauerwein; Chris J Drakeley; Teun Bousema
Journal:  Malar J       Date:  2012-08-08       Impact factor: 2.979

Review 6.  A research agenda for malaria eradication: monitoring, evaluation, and surveillance.

Authors: 
Journal:  PLoS Med       Date:  2011-01-25       Impact factor: 11.069

7.  Hitting hotspots: spatial targeting of malaria for control and elimination.

Authors:  Teun Bousema; Jamie T Griffin; Robert W Sauerwein; David L Smith; Thomas S Churcher; Willem Takken; Azra Ghani; Chris Drakeley; Roly Gosling
Journal:  PLoS Med       Date:  2012-01-31       Impact factor: 11.069

8.  Stability of gametocyte-specific Pfs25-mRNA in dried blood spots on filter paper subjected to different storage conditions.

Authors:  Michael Pritsch; Andreas Wieser; Victor Soederstroem; David Poluda; Teferi Eshetu; Michael Hoelscher; Soeren Schubert; Jonathan Shock; Thomas Loescher; Nicole Berens-Riha
Journal:  Malar J       Date:  2012-04-30       Impact factor: 2.979

9.  Strategies for detection of Plasmodium species gametocytes.

Authors:  Rahel Wampfler; Felistas Mwingira; Sarah Javati; Leanne Robinson; Inoni Betuela; Peter Siba; Hans-Peter Beck; Ivo Mueller; Ingrid Felger
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

10.  Comparison of three methods for detection of gametocytes in Melanesian children treated for uncomplicated malaria.

Authors:  Stephan Karl; Moses Laman; Tamarah Koleala; Clemencia Ibam; Bernadine Kasian; Nola N'Drewei; Anna Rosanas-Urgell; Brioni R Moore; Andreea Waltmann; Cristian Koepfli; Peter M Siba; Inoni Betuela; Robert C Woodward; Timothy G St Pierre; Ivo Mueller; Timothy M E Davis
Journal:  Malar J       Date:  2014-08-14       Impact factor: 2.979

View more
  3 in total

1.  Demographical, hematological and serological risk factors for Plasmodium falciparum gametocyte carriage in a high stable transmission zone in Cameroon.

Authors:  Estelle Essangui; Carole Else Eboumbou Moukoko; Niels Nguedia; Michele Tchokwansi; Umaru Banlanjo; Franklin Maloba; Balotin Fogang; Christiane Donkeu; Marie Biabi; Glwadys Cheteug; Sylvie Kemleu; Emmanuel Elanga-Ndille; Léopold Lehman; Lawrence Ayong
Journal:  PLoS One       Date:  2019-04-25       Impact factor: 3.240

2.  Gametocyte carriage after seasonal malaria chemoprevention in Plasmodium falciparum infected asymptomatic children.

Authors:  Abdullahi Ahmad; Aurelia Prom; John Bradley; Mamadou Ndiath; Blessed Etoketim; Mamadou Bah; Jean-Pierre Van Geertruyden; Chris Drakeley; Teun Bousema; Jane Achan; Umberto D'Alessandro
Journal:  Malar J       Date:  2021-03-26       Impact factor: 2.979

3.  Comparison of molecular quantification of Plasmodium falciparum gametocytes by Pfs25 qRT-PCR and QT-NASBA in relation to mosquito infectivity.

Authors:  Helmi Pett; Bronner P Gonçalves; Alassane Dicko; Issa Nébié; Alfred B Tiono; Kjerstin Lanke; John Bradley; Ingrid Chen; Halimatou Diawara; Almahamoudou Mahamar; Harouna M Soumare; Sekou F Traore; Ibrahima Baber; Sodiomon B Sirima; Robert Sauerwein; Joelle Brown; Roly Gosling; Ingrid Felger; Chris Drakeley; Teun Bousema
Journal:  Malar J       Date:  2016-11-08       Impact factor: 2.979

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.